Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach

Mahnken, Jonathan D.; Wenyaw Chan; Freeman Jr., Daniel H.; Freeman, Jean L.
December 2008
Statistical Methods in Medical Research;Dec2008, Vol. 17 Issue 6, p643
Academic Journal
Measuring the benefit of screening mammography is difficult due to lead-time bias, length bias and overdetection. We evaluated the benefit of screening mammography in reducing breast cancer mortality using observational data from the SEER-Medicare linked database. The conceptual model divided the disease duration into two phases: preclinical (T0) and symptomatic (T1) breast cancer. Censored information for the bivariate response vector (T0, T1) was observed and used to generate a likelihood function. However, the contribution to the likelihood function for some observations could not be calculated analytically, thus, censoring boundaries for these observations were modified. Inferences about the impact of screening mammography on breast cancer mortality were made based on maximum likelihood estimates derived from this likelihood function. Hazard ratios (95% confidence intervals) of 0.54 (0.48-0.61) and 0.33 (0.26- 0.42) for single and regular users (vs. non-users), respectively, demonstrated a protective effect of screening mammography among women 69 years and older. This method reduced the impact of lead-time bias, length bias and over-detection, which biased the estimated hazard ratios derived from standard survival models in favour of screening.


Related Articles

  • Breast cancer incidence and mortality in Tyrol/ Austria after fifteen years of opportunistic mammography screening. Oberaigner, Willi; Buchberger, Wolfgang; Frede, Thomas; Knapp, Rudolf; Marth, Christian; Siebert, Uwe // BMC Public Health;2010, Vol. 10 Issue 1, p86 

    Background: The aim of this study was to analyse breast cancer incidence and mortality in Tyrol from 1970 to 2006, namely after performing more than a decade of opportunistic mammography screening and just before piloting an organised screening programme. Our investigation was conducted on a...

  • Estimation of age- and stage-specific Catalan breast cancer survival functions using US and Catalan survival data. Vilaprinyo, Ester; Rué, Montserrat; Marcos-Gragera, Rafael; Martínez-Alonso, Montserrat // BMC Cancer;2009, Vol. 9, Special section p1 

    Background: During the last part of the 1990s the chance of surviving breast cancer increased. Changes in survival functions reflect a mixture of effects. Both, the introduction of adjuvant treatments and early screening with mammography played a role in the decline in mortality. Evaluating the...

  • Detection Dilemma. Begley, Sharon; Carmichael, Mary; Foote, Donna // Newsweek (Atlantic Edition);2/4/2002 (Atlantic Edition), Vol. 139 Issue 5, p51 

    Discusses the debate surrounding the effectiveness of mammograms in terms of survival of breast cancer. View of the National Cancer Institute (NCI) that mammography does not prolong the lives of younger women or those over 50; Impact of this conclusion on the numbers of women receiving...

  • Customize Starting Age and Frequency of Mammograms.  // Radiology Today;Aug2011, Vol. 12 Issue 8, p34 

    The article reports on the study which suggests that mammograms should be scheduled on a personalized basis as determined by factors such as a woman's age, her family history of breast cancer, and the density of her breasts.

  • Identification of Breast Cancer Using Integrated Information from MRI and Mammography. Yang, Shih-Neng; Li, Fang-Jing; Liao, Yen-Hsiu; Chen, Yueh-Sheng; Shen, Wu-Chung; Huang, Tzung-Chi // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Objectives: Integration of information from corresponding regions between the breast MRI and an X-ray mammogram could benefit the detection of breast cancer in clinical diagnosis. We aimed to provide a framework of registration from breast MRI to mammography and to evaluate the diagnosis using...

  • Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec. Dorval, Michel; Noguès, Catherine; Berthet, Pascaline; Chiquette, Jocelyne; Gauthier-Villars, Marion; Lasset, Christine; Picard, Claude; Plante, Marie; Simard, Jacques; Julian-Reynier, Claire // European Journal of Human Genetics;May2011, Vol. 19 Issue 5, p494 

    We described and compared breast and ovarian screening practices in the 2-year period following test result disclosure in female non-carriers from BRCA1/2 mutation-positive families living in two countries, France and Quebec, Canada, which provide universal health care. Four hundred and two...

  • Practitioner compression force variability in mammography: a preliminary study. MERCER, C. E.; HOGG, P.; LAWSON, R.; DIFFEY, J.; DENTON, E. R. E. // British Journal of Radiology;Feb2013, Vol. 86 Issue 1022, p1 

    Objective: This preliminary study determines whether the absolute amount of breast compression in mammography varies between and within practitioners. Methods: Ethics approval was granted. 488 clients met the inclusion criteria. Clients were imaged by 14 practitioners. Collated data included...

  • Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries. Wiernikowski, Jennifer; Mohide, E. Ann // Evidence Based Nursing;Jul2007, Vol. 10 Issue 3, p80 

    The article discusses research which revealed that adequately randomised trials showed mammography screening did not significantly decreased breast cancer, cancer or all cause mortality but increased breast surgeries. Mammography screening was linked with an increased risk of breast surgeries...

  • Swedish Mammography Study Shows Mortality Benefit.  // Radiology Today;Aug2011, Vol. 12 Issue 8, p32 

    The article reports on the study which reveals that breast cancer screening with mammography reduces breast cancer mortality in Sweden. The study suggests that evaluation of the full impact of screening mammography requires follow-up times exceeding 15-20 years because the observed number of...

  • Screening for breast cancer. Litherland, Janet // Journal of the British Menopause Society;2004, Vol. 10 Issue 1, p24 

    Mammographic screening for breast cancer commenced in the UK in 1988 following the recommendations of the Forrest Committee and is now well established. This article reviews the evidence for efficacy of mammographic screening, the mode of delivery of the service including the assessment of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics